Literature DB >> 27368805

Inactivated pepsin inhibits neutrophil activation by Fcgamma-receptor-dependent and independent stimuli.

Iwan Kustiawan1, Ninotska Derksen1, Theo Rispens2.   

Abstract

Pepsin is widely used to produce F(ab')2 fragments of immunoglobulin G (IgG). In many cases, at least part of the pepsin will remain present in the F(ab')2 preparation, albeit in (irreversibly) inactivated form. Here we report on a potent immunomodulatory effect of irreversibly inactivated pepsin on activated human neutrophils. Degranulation, induced by coated IgG or via cytochalasin B/N-formyl-Met-Leu-Phe, was measured by quantifying elastase release, and was found to be inhibited in a dose-dependent manner by inactivated pepsin. Since a number of intravenous immunoglobulin (IVIg) products are also treated by limited digestion with pepsin, we investigated if pepsin would be present in quantities large enough to inhibit neutrophil activation. The amounts of pepsin detected in three different pepsin-treated IVIg products were found to be too low to induce an effect, at least in an in vitro setting.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Immunomodulation; Intravenous immunoglobulin (IVIg); Neutrophil; Pepsin

Mesh:

Substances:

Year:  2016        PMID: 27368805     DOI: 10.1016/j.clim.2016.06.008

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  1 in total

1.  Intravenous immunoglobulin replacement treatment reduces in vivo elastase secretion in patients with common variable immune disorders.

Authors:  Alessandro Prezzo; Filomena M Cavaliere; Cinzia Milito; Caterina Bilotta; Metello Iacobini; Isabella Quinti
Journal:  Blood Transfus       Date:  2018-07-17       Impact factor: 3.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.